¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"visual field defect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual
    ½Ã·Â-, ½Ã°¢-
  • visual acuity
    ½Ã·Â
  • visual acuity test
    ½Ã·Â°Ë»ç
  • visual acuity test chart
    ½Ã·Â°Ë»çÇ¥
  • visual agnosia
    ½Ã°¢ÀνĺҴÉ(Áõ), ½Ã°¢½ÇÀÎÁõ
  • visual analogue scale
    ½Ã°¢¾Æ³¯·Î±×ôµµ, ½Ã°¢ÅëÁõµî±Þ
  • visual angle
    ½Ã°¢°¢
  • visual aphasia
    ½Ã°¢¾ð¾î»ó½ÇÁõ, ½Ã°¢½Ç¾îÁõ
  • visual area
    ½Ã°¢¿µ¿ª
  • visual association area
    ½Ã°¢¿¬ÇÕ¿µ¿ª
  • visual aura
    ½Ã°¢Á¶Áü
  • visual axis
    ½Ã¼±Ãà, ½ÃÃà
  • visual cell
    ½Ã°¢¼¼Æ÷
  • visual center
    ½Ã°¢ÁßÃß
  • visual cone
    ½Ã°¢¿ø»Ô
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • atrial septal defect
    ½É¹æ»çÀ̸·°á¼Õ, ½É¹æÁ߰ݰá¼Õ
  • atrioventricular canal defect
    ¹æ½Ç°ü°á¼Õ(Áõ)
  • atrioventricular septal defect
    ¹æ½Ç»çÀ̸·°á¼Õ(Áõ), ¹æ½ÇÁ߰ݰá¼Õ(Áõ)
  • auditory defect
    û°¢°á¼Õ
  • biochemical defect syndrome
    »ýÈ­ÇÐÀû°áÇÔÁõÈıº
  • canalization defect
    °üÇü¼º°áÇÔ
  • color vision defect
    »ö°¢°áÇÔ
  • composition defect
    ±¸¼º°áÇÔ
  • conduction defect
    ÀüµµÀå¾Ö
  • congenital defect
    ¼±Ãµ°áÇÔ, ¼±Ãµ°á¼Õ(Áõ)
  • conjunction defect
    °áÇÕ°áÇÔ
  • cortical sensory defect
    °ÑÁú°¨°¢°á¼Õ
  • defect
    °áÇÔ, °á¼Õ(Áõ)
  • defect rate
    °áÇÔ·ü
  • differentiation defect
    ºÐÈ­°áÇÔ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • remediable defect
    Ä¡À¯°¡´É°áÇÔ(ö½ë¨Ê¦ÒöÌÀùè).
  • remediable defect
    Ä¡À¯°¡´É°áÇÔ(ö½ë¨Ê¦ÒöÌÀùè)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • visual direction
    ½Ã¹æÇâ
  • visual directive line
    ½Ã¹æÇâ¼±(ãÊÛ°ú¾àÊ).
  • visual discrimination
    ½Ã°¢½Äº°
  • visual discriminatory acuity
    ½Ã°¢½Äº°µµ(ãÊÊÆãÛܬöô).
  • visual disorder =v. disturbance
    ½Ã°¢Àå¾Ö(¡­î¡äô)
  • visual disturbance
    ½Ã°¢Àå¾Ö.
  • visual efficiency
    ½ÃÈ¿À².
  • visual evoked potential
    ½ÃÀ¯¹ßÀüÀ§
  • visual evoked potential
    ½Ã°¢À¯¹ßÀüÀ§.
  • visual evoked response
    ½ÃÀ¯¹ß¹ÝÀÀ
  • visual fatigue
    ½Ã°¢ÇÇ·Î
  • visual focus
    ½Ã°¢ÃÊÁ¡(¡­õ¥ïÇ).
  • visual function
    ½Ã±â´É
  • visual hallucination
    ȯ½Ã
  • visual hallucination
    ȯ½Ã(ü³ãÊ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Umbilical cord defect
    ÅÈÁÙ°áÇÔ
    [¿¾ ¿ë¾î] Á¦´ë°áÇÔ
  • Retroplasty defect (Double superior vena cava)
    ÅðÇà°áÇÔ (°ãÀ§´ëÁ¤¸Æ)
    [¿¾ ¿ë¾î] ÅðÇຯ¼º°áÇÔ (°ãÀ§´ëÁ¤¸Æ)
  • Retroplasia defect
    ÅðÇຯ¼º°áÇÔ
    [¿¾ ¿ë¾î] ÅðÇຯ¼º°áÇÔ
  • Metabolic defect of nucleic acid (Purinemia)
    ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
    [¿¾ ¿ë¾î] ÇÙ»ê´ë»ç°áÇÔ(Ç»¸°Ç÷Áõ)
  • Hormone defect (Hermaphroditism)
    È£¸£¸ó°áÇÔ (¹ÝÀ½¾çÁõ)
    [¿¾ ¿ë¾î] È£¸£¸ó°áÇÔ (¹ÝÀ½¾çÁõ)
  • Meoitic defect
    °¨¼öºÐ¿­°áÇÔ
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­±â°áÇÔ
  • Promeiotic defect
    °¨¼öºÐ¿­ÀÌÀü°áÇÔ
    [¿¾ ¿ë¾î] °¨¼öºÐ¿­Àü°áÇÔ
  • Conjunction defect
    °áÇÕ°áÇÔ
    [¿¾ ¿ë¾î] °áÇÕ°áÇÔ
  • Composition defect
    ±¸¼º°áÇÔ
    [¿¾ ¿ë¾î] ±¸¼º°áÇÔ
  • Simple morphologic defect
    ´Ü¼øÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ü¼ø¼ºÇüÅÂÇÐÀû°áÇÔ
  • Defect of embryogenesis
    ¹èÀڹ߻ý°áÇÔ
    [¿¾ ¿ë¾î] ¹èÀÚÇü¼º°áÇÔ
  • Multiple morphologic defect
    º¹ÇÕÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÇüÅÂÇÐÀû°áÇÔ
  • Defect of Integument
    ¿ÜÇǰáÇÔ
    [¿¾ ¿ë¾î] ¿ÜÇǰáÇÔ
  • Genetic defect
    À¯ÀüÀÚ°áÇÔ
    [¿¾ ¿ë¾î] À¯ÀüÇÐÀû°áÇÔ
  • Chorionic defect
    À¶¸ð¸·°áÇÔ
    [¿¾ ¿ë¾î] À¶¸ð¸·°áÇÔ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • static field inhomogeneity
    Á¤ÀÚÀåºÒ±ÕÁú
  • static magnetic field
    Á¤ÀÚÀå
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • upper lung field
    »óÆó±¸¿ª, »óÆó¾ß
  • vertical field magnet
    ¼öÁ÷ÀÚÀåÀÚ¼®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
VHF very high frequency; viral hemorrhagic fever; visual half-field
AVC aberrant ventricular conduction; Academy of Veterinary Cardiology; aortic valve closure; associative...
VC color vision; variance cardiography; vascular changes; vasoconstriction; vena cava; venereal case; v...
VDT vibration disappearance threshold; visual display terminal; visual distortion test
VI Roman numeral six; vaginal irrigation; variable interval; vastus intermedius; virgo intacta; virulen...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
BCVA Best corrected visual acuity
BSCVA Best spectacle corrected visual acuity
CVI Cortical visual impairment
DVA Dynamic visual acuity
FVEP Flash visual evoked potentials
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • equivalent field
    µî°¡ Á¶»ç ¿µ¿ª
  • eye field
    ½Ã¾ß
  • far field
    ¿ø°Å¸® ±¸¿ª
  • field
    ±¸¿ª, ¾ß, ¿µ¿ª
    1. ÀÛ¿ë ¿µ¿ª ¶Ç´Â Àå¼Ò³ª °ø°£. 2. Áö½Ä, ¿¬±¸, Á÷¾÷¿¡ À־ÀÇ Àü¹® ºÐ¾ß. 3. ¹ß»ýÇп¡ ÀÖ¾î º¯µ¿ ¿äÀÎÀÇ ¹üÀ§ ³»¿¡¼­ ºÐÈ­ÇÏ´Â ¿µ¿ª.
  • field cancerization
    ±¸¿ª ¾ÏÈ­
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
  • field profile
    ÀÚÀå Ãø¸é »ó
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁö Á¶»ç
  • fringe field
    ÁÖº¯ ¾ß
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • intermediate field MR scanner
    Áßµî ÀÚÀå Àڱ⠰ø¸í ½ºÄ³³Ê
  • irradiation field
    Á¶»ç ¾ß
  • magnet field homogeneity
    ÀÚÀå ±ÕÁú¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
visual organ The eye and its adnexa.
Synonym: organum visus, organ of vision.
(05 Mar 2000)
visual pathway Neural paths and connections within the central nervous system, beginning with the retina and terminating in the occipital cortex.
(05 Mar 2000)
visual perception The selecting and organizing of visual stimuli based on the individual's past experience.
(12 Dec 1998)
visual pigments The photopigments in the retinal cones and rods that absorb light and initiate the visual process.
(05 Mar 2000)
visual projection A perceptual synthesis involving visual mechanisms.
(05 Mar 2000)
visual purple <protein> Light sensitive pigment formed from retinal linked through a Schiff's base to opsin: rhodopsin is an integral membrane protein found in the discs of retinal rods and cones, comprising some 40% of the membrane. Vertebrate opsins are proteins of 38 kD.
See: bacteriorhodopsin.
(18 Nov 1997)
visual receptor cells The rod and cone cell's of the retina.
(05 Mar 2000)
visual-spatial agnosia The inability to localise objects or to appreciate distance, motion, and spatial relationships; caused by lesion in the occipital lobe.
Compare: simultanagnosia.
(05 Mar 2000)
visual threshold Threshold of visual sensation, the minimal light intensity evoking a visual sensation.
Synonym: achromatic threshold, minimum light threshold.
(05 Mar 2000)
visual violet A visual pigment, composed of 11-cis-retinal bound to an opsin, found in the cones of the retina.
Synonym: visual violet.
Origin: G. Ion, violet, + ops, eye, + -in
(05 Mar 2000)
visual yellow The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin.
Synonym: trans-retinal, visual yellow.
(05 Mar 2000)
primary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
primary visual cortex See: visual cortex.
(05 Mar 2000)
secondary visual area Area of the occipital lobe concerned with vision.
(12 Dec 1998)
secondary visual cortex See: visual cortex.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • field length
    ÀÌÂø·ú ȰÁÖ °Å¸®
  • field lens
    ´ë¹° ·»Áî;½Ã¿ª ·»Áî
  • field line
    ÈûÀÇ ¼±
  • field magnet
    °èÀÚ;ÀåÀÚ¼®
  • field method
    ¾ß¿Ü ¿¬±¸¹ý !
  • field mouse
    µéÁã
  • field music
    ±º¾Ç´ë(±º¾Ç ´ë¿ë)ÇàÁø°î
  • field officer
    À°±ºÀÇ ¿µ°ü±Þ Àå±³
  • field preacher
    ¾ß¿Ü Àüµµ»ç(¼³±³»ç)
  • field punishment
    ÀüÁö Çü¹ú 
  • field ration
    ¾ßÀü¾ç½Ä
  • field recording
    ÇöÁö ³ìÀ½
  • field secretary
    ¿Ü±Ù Á÷¿ø;Áö¹æ ¿¬¶ô¿ø
  • field service
    ¾ßÀü±Ù¹«
  • field sports
    ¾ß¿Ü ¿îµ¿;À¯·Æ;ÇÊµå °æ±â Á¾¸ñ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á